Reference ID: 3973669 - Food and Drug Administration
tolerating INVOKANA 100 mg once daily who have an eGFR of 60 mL/min/1.73 m. 2 . or greater and require additional glycemic control [see Drug Interactions (7.1)]
Download Reference ID: 3973669 - Food and Drug Administration
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
Cordarone Ant Intravenous - Amiodarone-IV
amiodaroneiv.comCordarone I.V. also can be used to treat patients with VT/VF for whom oral Cordarone is indicated, but who are unable to take oral medication. During or after treatment with Cordarone I.V., patients may be
Item 320 : Ictère - CAMPUS NUMERIQUES
campus.cerimes.fr- Support de Cours (Version PDF) - Le flux biliaire n’est pas généré par la sécrétion de bilirubine, mais par un transport actif de substances osmotiques : les acides biliaires (fig. 36.3).Une diminution de
INTERPRETING YOUR BLOOD TESTS (and more) …
www.pscpartners.orgINTERPRETING YOUR BLOOD TESTS (and more) Christopher L. Bowlus, MD . University of California Davis . April 30, 2011 . TEST What does it mean? When should I worry?
DOSAGE FORMS AND STRENGTHS ... - accessdata.fda.gov
www.accessdata.fda.gov2.4 . Dosing for Liver Transplant Patients: Adults . The recommended dose of CELLCEPT for adult liver transplant patients is 1.5 g administered orally twice daily (daily dose of 3 g) or 1 g infused intravenously over no less than 2 hours, twice
Clinical Diagnostic Laboratory Services - cms.gov
www.cms.govSection 4554(b)(1) of the Balanced Budget Act of 1997 (BBA), Public Law 10533, mandated - the use of a negotiated rulemaking committee to develop national coverage and administrative
CMS Manual System
www.cms.govCMS Manual System Department of Health & Human Services (DHHS) Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 3902 Date: November 3, 2017